Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Brochure More information from http://www.researchandmarkets.com/reports/3150156/ Orally Inhaled Corticosteroids to 2022 Description: Asthma continues to be a health segment that presents challenges to the caregiver community. Patient adherence with prescribing instructions and treatment protocols remains sub-optimal across all patient categories, but particularly for the young and the elderly. This has led to significant interest on the part of device and combination product providers directed toward the development easier-to-use inhalers. Because they reduce inflammation and swelling in the airways, orally inhaled corticosteroids are an indispensable tool for the treatment of asthma. The market entry of combination drug inhalers that deliver a corticosteroid and a bronchodilator from the same inhaler are providing important options for both clinicians and patients. Contents: 1.Executive Summary 2. Orally Inhaled Corticosteroid Market Overview 3.The Asthma Therapeutics Marketspace Competing Drug Treatments Corticosteroids and Asthma Demand Drivers Technology Factors Competitive Landscape 4. Asthma Market Risks and Opportunities 5.Global Patient Demographics Regional Market Drivers Pediatric Asthma –the Growing Therapeutic Need 6. Inhaler Technologies for Delivering Corticosteroids 7. Dry Powder Inhalers DPI Formulation Technology Characteristics and Parameters DPI Excipients and Packaging Metered Dose Inhalers MDI Device Selection Criteria Ease-of-Use Factors Nebulizers 8. Inhaled Corticosteroids – Product Analysis, Market Data & Forecasts 9. Beclomethasone, QVAR 40/80 (MDI) Budesonide, Pulmicort (DPI) Budesonide, Pulmicort (Nebulizer) Generic Budesonide (Nebulizer) Budesonide/Formoterol (Symbicort) Combination Drug Inhaler (MDI) Ciclesonide, Alvesco (MDI) Ciclesonide, Zetonna (MDI) Flunisolide, Aerospan HFA (MDI) Fluticasone, Arnuity Ellipta (DPI) Fluticasone, Flovent HFA (MDI) Fluticasone, Flovent Diskus50/100/250 (DPI) Fluticasone/Salmeterol (Advair HFA) Combination Drug Inhaler (MDI) Fluticasone/Salmeterol (Advair Diskus) Combination Drug Inhaler (DPI) Fluticasone/Vilanterol (Breo Ellipta) Combination Drug Inhaler (DPI) Mometasone, Asmanex HFA (MDI) Mometasone, Asmanex Twisthaler (DPI) Umeclidinium, Incruse Ellipta (DPI) Umeclidinium/Vilanterol (Anora Ellipta) Combination Drug Inhaler (DPI) 10. Market Factors 11. Regulatory Issues Patient Compliance Prescribing Trends Healthcare Economics Regional Market Factors Connected Devices 12. Market Sector Company Profiles Ordering: Order Online - http://www.researchandmarkets.com/reports/3150156/ Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland. Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit http://www.researchandmarkets.com/contact/ Order Information Please verify that the product information is correct and select the format(s) you require. Product Name: Orally Inhaled Corticosteroids to 2022 Web Address: http://www.researchandmarkets.com/reports/3150156/ Office Code: SCHL3FA7 Product Formats Please select the product formats and quantity you require: Quantity Electronic (PDF) Single User: USD 2850 Electronic (PDF) Site License: USD 4500 Electronic (PDF) Enterprisewide: USD 6500 Contact Information Please enter all the information below in BLOCK CAPITALS Title: First Name: Mr Mrs Dr Miss Last Name: Email Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL) Ms Prof Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card: You will receive an email with a link to a secure webpage to enter your credit card details. Pay by check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland. Pay by wire transfer: Please transfer funds to: Account number 833 130 83 Sort code 98-53-30 Swift code ULSBIE2D IBAN number IE78ULSB98533083313083 Bank Address Ulster Bank, 27-35 Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World